Wall Street analysts expect that Nutrien Ltd (NYSE:NTR) will announce sales of $3.62 billion for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Nutrien’s earnings, with the lowest sales estimate coming in at $3.24 billion and the highest estimate coming in at $4.09 billion. Nutrien reported sales of $3.76 billion in the same quarter last year, which would suggest a negative year over year growth rate of 3.7%. The company is expected to issue its next quarterly earnings results on Wednesday, February 5th.
On average, analysts expect that Nutrien will report full year sales of $19.73 billion for the current fiscal year, with estimates ranging from $19.05 billion to $20.57 billion. For the next year, analysts anticipate that the company will post sales of $21.16 billion, with estimates ranging from $19.74 billion to $23.57 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research analysts that cover Nutrien.
Nutrien (NYSE:NTR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.24 earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.12). The firm had revenue of $4.13 billion for the quarter, compared to analysts’ expectations of $4.02 billion. Nutrien had a net margin of 20.95% and a return on equity of 6.49%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.47 EPS.
NTR has been the topic of several research analyst reports. ValuEngine upgraded Nutrien from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. TD Securities reduced their price target on Nutrien from $69.00 to $67.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Sanford C. Bernstein cut Nutrien from an “outperform” rating to a “market perform” rating and reduced their price target for the stock from $68.00 to $53.00 in a report on Wednesday. Zacks Investment Research cut Nutrien from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 8th. Finally, Bank of America raised Nutrien from a “neutral” rating to a “buy” rating and set a $54.00 price target for the company in a report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the stock. Nutrien has a consensus rating of “Buy” and a consensus price target of $58.94.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Sprott Inc. raised its stake in shares of Nutrien by 4.4% in the second quarter. Sprott Inc. now owns 7,546 shares of the company’s stock valued at $403,000 after acquiring an additional 315 shares in the last quarter. Commonwealth Bank of Australia boosted its holdings in Nutrien by 46.1% in the 2nd quarter. Commonwealth Bank of Australia now owns 1,318 shares of the company’s stock valued at $69,000 after purchasing an additional 416 shares in the last quarter. HM Capital Management LLC boosted its holdings in Nutrien by 1.3% in the 3rd quarter. HM Capital Management LLC now owns 42,081 shares of the company’s stock valued at $2,099,000 after purchasing an additional 535 shares in the last quarter. Hancock Whitney Corp boosted its holdings in Nutrien by 9.5% in the 3rd quarter. Hancock Whitney Corp now owns 6,770 shares of the company’s stock valued at $338,000 after purchasing an additional 586 shares in the last quarter. Finally, AE Wealth Management LLC boosted its holdings in Nutrien by 2.2% in the 3rd quarter. AE Wealth Management LLC now owns 31,632 shares of the company’s stock valued at $1,578,000 after purchasing an additional 668 shares in the last quarter. Institutional investors and hedge funds own 63.88% of the company’s stock.
Shares of NTR traded down $0.51 during trading hours on Monday, hitting $47.43. The company had a trading volume of 26,808 shares, compared to its average volume of 1,032,403. Nutrien has a one year low of $45.82 and a one year high of $56.00. The company’s fifty day moving average price is $47.57 and its two-hundred day moving average price is $49.59. The company has a current ratio of 1.28, a quick ratio of 0.77 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $27.46 billion, a PE ratio of 17.61, a price-to-earnings-growth ratio of 2.09 and a beta of 0.90.
The company also recently declared a quarterly dividend, which will be paid on Thursday, January 16th. Stockholders of record on Tuesday, December 31st will be given a dividend of $0.45 per share. The ex-dividend date of this dividend is Monday, December 30th. This represents a $1.80 annualized dividend and a dividend yield of 3.80%. Nutrien’s dividend payout ratio is currently 66.91%.
Nutrien Company Profile
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Recommended Story: Understanding the different types of bonds
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.